Pruritus Pipeline Report: Encapsulates all the Dormant and Discontinued Pipeline Projects

Pruritus, or itch, is defined as an unpleasant sensation that provokes the desire to scratch. Pruritus is caused by cancer, cancer treatments, infection, dry skin and reaction to a drug. Symptoms include redness, bumps, spots or blisters, dry, cracked skin and leathery or scaly texture to the skin. Risk factors include heat, allergic, asthma, hay fever, hives and eczema. Treatment includes corticosteroids, antihistamines and antidepressants.

Report Source:


  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Pruritus (Dermatology) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Pruritus (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Pruritus (Dermatology)

Purchase this report at:

Reasons To Buy

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Pruritus (Dermatology).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Pruritus (Dermatology) pipeline depth and focus of Indication therapeutics.

Companies Mentioned

  • Albireo Pharma Inc
  • Amgen Inc
  • AOBiome LLC
  • Asana BioSciences LLC
  • Cara Therapeutics Inc
  • Celgene Corp
  • Chugai Pharmaceutical Co Ltd
  • ELORAC Inc
  • GlaxoSmithKline Plc
  • Hanlim Pharm Co Ltd
  • Hydra Biosciences Inc
  • Jiangsu Hengrui Medicine Co Ltd
  • Menlo Therapeutics Inc
  • NeuroCycle Therapeutics GmbH
  • Patagonia Pharmaceuticals LLC
  • RDD Pharma Ltd
  • Roivant Sciences Ltd
  • Saniona AB
  • Sanwa Kagaku Kenkyusho Co Ltd
  • Sienna Biopharmaceuticals Inc
  • Sumitomo Dainippon Pharma Co Ltd
  • Teikoku Pharma USA Inc
  • Tioga Pharmaceuticals Inc
  • Toray Industries Inc
  • Vanda Pharmaceuticals Inc

Got a question; ask us at: